That very recent article about EPA being useful in reducing cardiac events was published by Japanese researchers and is very relevant to the discussion here. The FDA has been duly notified of this important information which came out on 9/18 in a peer reviewed journal. This is the warning shot to the shorts still in this game. John Capello did a fine job of informing the FDA of this salient article. Now let's see how AdCom deals with this info ( I suspect it will like it).
The AHA response about JELIS study was neutral...one of doctors based out of Hawaii said it was interesting results but it needed more data.... It is unfortunate but FDA tends to think they are all alone in the top of world.... And, this can go both ways but there is also a possibility they need more data......That is the game on this more data.......and when they go home probably they are taking their own fish oil capsules....out of pocket of course